This research is based on the scope and definitions for Drug Utilization Review (DUR) program in the U.S., Code of Federal Regulation, Public Health (OBRA 90). An outpatient program includes prospective drug review, retrospective drug use review and an educational program. The goal of the DUR program must be to ensure appropriate drug therapy, while permitting sufficient professional prerogatives to allow for individualized drug therapy. A DUR program must access drug use information against predetermined standards. The source materials for predetermined standards development are consistent with peer reviewed medical literature and compendia such as American Hospital Formulary Service Drug Information, United States Pharmacopoeia-Drug Information and American Medical Association Drug Evaluations. The predetermined standards for prospective and retrospective DUR are compatible and subjected to ongoing evaluation and modification by the DUR Board. A system of drug use review that can detect potential adverse drug interaction, therapeutic duplication, drug age conflicts, etc. Therefore drug information to integrate into a DUR system is developed electronically based on the predetermined standards guidelines by commercial vendors of DUR services contracted with State agency. Differences between source materials were resolved by expertise of physicians and pharmacists to come agreement.
목차
Abstract Prospective DUR Retrospective DUR 기결정된 표준의 사용 DUR 교육 프로그램 FirstDataBank (FDB) 참고문헌
키워드
DUR ProgramDUR SystemPredetermined Standard Drug Information
한국보건사회약료경영학회 [Korean Academy of Social & Managed Care Phemacy]
설립연도
2009
분야
의약학>약학
소개
본 학회는 비영리 학술단체로서 환자의 삶의 질 향상을 위한 약료(pharmaceutical care)가 보장될 수 있도록 약료경영약학(managed care pharmacy)을 발전시키는 데 궁극 목적을 두고 다음과 같은 활동을 전개하여 사회에 기여하며 회원 상호간의 친목을 도모한다.
간행물
간행물명
한국보건사회약료경영학회지 [Journal of Korean Academy of Managed Care Pharmacy]